AtaCor MedicalJanuary 15, 2026Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
AtaCor MedicalOctober 9, 2025AtaCor Medical Secures $75M Financing to Support the Pivotal U.S. Study of its Extravascular ICD (EV-ICD) System
AtaCor MedicalApril 29, 2024ATACOR MEDICAL CLOSES $28M SERIES C FINANCING TO DELIVER NEXT GENERATION EXTRAVASCULAR ICD AND PACING OPTIONS FOR CARDIAC RHYTHM MANAGEMENT
AtaCor MedicalNovember 3, 2022AtaCor Medical to Present Acute and 3 Month Results from Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Studies
AtaCor MedicalApril 29, 2022AtaCor Medical to Present Preliminary Results from First-in-Human Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study
AtaCor MedicalDecember 20, 2021AtaCor Medical Completes Enrollment in its Initial Acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Study
AtaCor MedicalApril 28, 2020AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
AtaCor MedicalApril 29, 2020Atacor Raises $25M to Make Regulatory Case for Temporary Extracardiac Cardiac Pacing
